Vaccine Choice Canada COVID-19 - Vaccine Choice Canada

COVID-19

COVID is a respiratory condition similar to influenza. Covid-19 is assumed to be a viral infection that produces fever, chills, sore throat, muscle aches, and cough that can last a week or more. The vast majority of people naturally recover from Covid-19 without any complications and develop immunity to future infection with the same strain or a related SARS strain. This may prevent illness symptoms or make illness less severe. The risk of Covid-19 has been assessed as similar to a mild to moderate influenza. Children and healthy individuals under the age of 50 years are not at risk from Covid-19.

The Vaccine

The vaccine utilizes the use of mRNA, a genetic platform, whose long-term effects are unknown.
The vaccine does not confer lasting protection. Boosters are required every six months.
The vaccine does not prevent infection or transmission.
The vaccine was approved based on subjective preliminary findings with no mid or long-term safety data, and no objective proof of efficacy with regard to hospitalization, complications, or deaths.
The infection fatality rate of COVID-19 is estimated to be about 0.05% for individuals under 70 years, in line with influenza. The median age of a “COVID-19 death” was above 80 years, and over 90% of deaths occurred in individuals with one or more comorbid conditions.
Since most people were not at serious risk from the virus, the government’s COVID-19 vaccine drive was dependent on fostering a sense of collective benefit to justify infringements on individual rights. Public benefit was never established nor quantified for the vaccine mandates or passports.

Considerations for the Vaccine Decision

The government disregarded well-established scientific methodology and bi-passed their usual requirements for drug approval, giving COVID-19 vaccines a free pass when it came to proving safety, efficacy or conducting a proper benefit-harm assessment.
Deceptive language was used to assure Canadians that the genetic vaccines were safe and effective — a claim they never had to back legally nor scientifically.
In the original mRNA clinical trial protocols, study participants were to be followed for two years after their second dose. Instead, recipients who were given a placebo were offered the vaccine after completing 6 months of follow-up. This eliminated the control group, thus preventing any rigorous assessment of long-term safety.
The COVID vaccine has resulted in the reporting of more adverse events following vaccination than the total number of adverse events of all vaccines combined over a 30-year period.
The federal and provincial governments circumvented Charter protections that sought to guarantee an individual the right to medical choice.
The safety of the Covid-19 vaccine has not been proven against a true placebo.
Health Canada continues to recommend that breastfeeding women get vaccinated and stay up to date with their COVID-19 vaccines despite inadequate data on the effects of vaccination on the breastfed baby, and on milk production or excretion.

For more information: https://www.nvic.org/disease-vaccine/covid19

Studies

eBioMedicine (Sept 19, 2023) – Biodistribution of mMRA COVID-19 vaccines in human breast milk [57]
A recent study revealed the mRNA from COVID-19 vaccines does not remain at the injection site but spreads systemically throughout the body and can even end up in breast milk passed on to infants by their vaccinated mothers.
Forensic Science International (June 21, 2024) – A Systematic REVIEW of Autopsy findings in deaths after covid-19 vaccination [58]
It was found that 73.9% of deaths were directly due to or significantly contributed to by COVID-19 vaccination.
The data suggest a high likelihood of a causal link between COVID-19 vaccination and death.
These findings indicate the urgent need to elucidate the pathophysiologic mechanisms of death with the goal of risk stratification and avoidance of death for the large numbers of individuals who have taken or will receive one or more COVID-19 vaccines in the future.
This review helps provide the medical and forensic community a better understanding of COVID-19 vaccine fatal adverse events.

References

[57] https://www.thelancet.com/journals/ebiom/article/PIIS2352-3964(23)00366-3/fulltext#%20

[58] https://www.sciencedirect.com/science/article/pii/S0379073824001968